SENP1 and prostate carcinoma: For instance, in vitro downregulation of miR-145 has been associated with increased SENP1 expression levels in prostate cancer tissue samples, while enhanced expression of miR-145 has been proven to result in cell cycle arrest by blocking SENP1 [58].